Sunshine Biopharma Inc. (SBFM) is a publicly traded Healthcare sector company. As of August 26, 2026, SBFM trades at $1.11 with a market cap of $4.50M and a P/E ratio of -0.31. SBFM moved -9.21% today. Year to date, SBFM is -91.09%; over the trailing twelve months it is -91.86%. Its 52-week range spans $1.03 to $39.00. Rallies surfaces SBFM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SBFM combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.11 |
| Market Cap | $4.50M |
| P/E Ratio | -0.31 |
| EPS | $-3.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.00 |
| 52-Week Low | $1.03 |
| Volume | 6.43M |
| Avg Volume | 0 |
| Revenue (TTM) | $35.35M |
| Net Income | $-5.83M |
| Gross Margin | 30.30% |
SBFM analyst coverage data. Average price target: $0.00.